NCT04858789

Brief Summary

The effectiveness study for Culturally Adapted Cognitive Behavioral Intervention will be conducted with university students to measure if this intervention if effective for decreasing the university students' psychological distress and increase their well-being during the COVID-19 pandemic. Potential participants will be given an informed consent and included in a screening procedure to decide their eligibility. 100 participants (50 in experimental and 50 in control group-randomly assigned) who pass the screening procedure will be invited to the effectiveness study. The experimental group will receive an 8-session intervention while the control group will receive information about the freely available psychological support options. The measurements will be conducted three times; one week before, one week after and five weeks after the intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 26, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

June 24, 2021

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2021

Completed
Last Updated

September 7, 2023

Status Verified

August 1, 2023

Enrollment Period

21 days

First QC Date

April 22, 2021

Last Update Submit

September 6, 2023

Conditions

Keywords

Culturally adaptedCovid-19Psychological distressUniversity studentsWell-beingOnline intervention

Outcome Measures

Primary Outcomes (1)

  • Comparison of changes of the Kessler-10 Psychological Distress Scale (K10) over time

    Kessler-10 Psychological Distress Scale is a 10-item scale that aims to measure the psychological distress. Each item is scored from 1 (none of the time) to 5 (all of the time) providing a range between 10 and 50. Higher scores indicate more severe psychological distress.

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)]

Secondary Outcomes (4)

  • Comparison of changes of the Patient Health Questionnaire-9 (PHQ-9) over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)]

  • Comparison of changes of the General Anxiety Disorder-7 (GAD-7) over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)

  • Comparison of changes of the PTSD Checklist for The Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5) (PCL-5) over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)

  • Comparison of changes of the World Health Organization (Five) Well-Being Index (WHO-5) over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)

Other Outcomes (3)

  • Comparison of changes of the Dispositional Hope Scale over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)]

  • Comparison of changes of the Emotion Regulation Questionnaire over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)]

  • 8. Comparison of changes of the Acceptance and Action Questionnaire-II (AAQ-II) over time

    Change from baseline (One week before the intervention) to follow-up assessment (13 weeks after the pre-assessment)

Study Arms (2)

Culturally Adapted Cognitive Behavioral Intervention (CA-CBI)

EXPERIMENTAL

The experimental group will receive an 8-session CA-CBI in an online group format.

Behavioral: Culturally Adapted Cognitive Behavioral Intervention (CA-CBI)

Control

NO INTERVENTION

The control (care as usual) group will receive the information about freely available psychological support options. After all the measurements are completed, the control group will be able to receive CA-CBI, too.

Interventions

CA-CBI is an intervention based on Culturally Adapted Cognitive Behavioral Therapy (CA-CBT) which was developed by Devon Hinton. This transdiagnostic intervention has a structured manual which can be culturally adapted and it will be used to decrease psychological distress and increase well-being by targeting cognitive and behavioral changes.

Culturally Adapted Cognitive Behavioral Intervention (CA-CBI)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being 18 years or above
  • Being a university student
  • Scoring 16 or above on Kessler Psychological Distress Scale (K10)
  • Scoring 14 or belove on Patient Health Questionnaire-9 (PHQ-9)

You may not qualify if:

  • Being older than 30 years
  • Imminent suicidal risk
  • Living outside of Turkey
  • Having any type of psychiatric disorder
  • Receiving any specialized psychological or psychiatric treatment at the time of application to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koc University

Istanbul, Turkey (Türkiye)

Location

Related Publications (7)

  • Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG, Pollack MH. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress. 2005 Dec;18(6):617-29. doi: 10.1002/jts.20070.

    PMID: 16382423BACKGROUND
  • Hinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct;17(5):429-33. doi: 10.1023/B:JOTS.0000048956.03529.fa.

    PMID: 15633922BACKGROUND
  • Huang J, Nigatu YT, Smail-Crevier R, Zhang X, Wang J. Interventions for common mental health problems among university and college students: A systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 Dec;107:1-10. doi: 10.1016/j.jpsychires.2018.09.018. Epub 2018 Sep 29.

    PMID: 30300732BACKGROUND
  • Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020 Oct;89:531-542. doi: 10.1016/j.bbi.2020.05.048. Epub 2020 May 30.

    PMID: 32485289BACKGROUND
  • Carlbring P, Andersson G, Cuijpers P, Riper H, Hedman-Lagerlof E. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther. 2018 Jan;47(1):1-18. doi: 10.1080/16506073.2017.1401115. Epub 2017 Dec 7.

    PMID: 29215315BACKGROUND
  • Cao W, Fang Z, Hou G, Han M, Xu X, Dong J, Zheng J. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Res. 2020 May;287:112934. doi: 10.1016/j.psychres.2020.112934. Epub 2020 Mar 20.

    PMID: 32229390BACKGROUND
  • Acarturk ZC, Abuhamdeh S, Jalal B, Unaldi N, Alyanak B, Cetinkaya M, Gulen B, Hinton D. Culturally adapted transdiagnostic CBT for SSRI resistant Turkish adolescents: A pilot study. Am J Orthopsychiatry. 2019;89(2):222-227. doi: 10.1037/ort0000310. Epub 2018 Jan 18.

    PMID: 29345479BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Ekin Çakır, PhD Student

    Koç University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2021

First Posted

April 26, 2021

Study Start

June 24, 2021

Primary Completion

July 15, 2021

Study Completion

August 15, 2021

Last Updated

September 7, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations